Picture of the author

Eddy

10/26 07:34

Danone CFO says its business could benefit from anti-obesity drugs

PARIS, Oct 26 (Reuters) - French food company Danone is looking positively into the impact that appetite suppressing anti-obesity drugs could have on its business, Finance Chief Juergen Esser told analysts during a call.

“If anything it will benefit our business,” Esser said, pointing to Danone’s health-focused portfolio and its businesses that include Medical Nutrition.

Reporting by Dominique Vidalon; Editing by Sudip Kar-Gupta

Our Standards: The Thomson Reuters Trust Principles.

1Chia sẻ

Tất cả bình luận0Mới nhấtPhổ biến

avatar
Mới nhấtPhổ biến